Conference Call Announcements

Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024

by

EMERYVILLE, Calif., Feb. 8, 2024 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2023 financial results on Thursday, February 22, 2024, after the U.S. financial markets close. Dynavax will host a conference call and live audio webcast on Thursday, … Read more

Volition Presents at the 5th Annual Congress of the International Liquid Biopsy Society

by

HENDERSON, Nev, Nov. 17, 2023 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, is presenting at the 5th Annual Congress of Liquid Biopsy being held in Madrid, Spain. Lea Payen-Gay, Professor in Toxicology and Biochemistry, University of Lyon I Hospices Civils de Lyon, France and Dr. Jake Micallef, Chief Scientific Officer, Volition … Read more

PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023

by

EMERYVILLE, Calif., Aug. 9, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the second quarter 2023 after market on Monday, August 14, 2023. About PhenomeX Inc. PhenomeX is empowering scientists to leverage the full potential of each cell and drive the … Read more

111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023

by

SHANGHAI, May 25, 2023 /PRNewswire/ — 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before the U.S. market opens … Read more

Newtopia Schedules First Quarter 2023 Earnings Release and Conference Call

by

TORONTO, May 24, 2023 /PRNewswire/ – Newtopia Inc. (“Newtopia” or the “Company“) (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled whole health platform creating sustainable habits that prevent, slow, and reverse chronic disease, announced today that it will release its financial results for the quarter ended March 31, 2023, after market close on Tuesday, May 30, 2023. … Read more

DocuSign Announces Timing of First Quarter Fiscal 2024 Earnings Conference Call

by

SAN FRANCISCO, May 18, 2023 /PRNewswire/ — DocuSign (Nasdaq: DOCU) today announced that its first quarter fiscal 2024 results will be released on Thursday, June 8, 2023, after the close of the market. The company will host a conference call at 1:30 p.m. Pacific Standard Time (4:30 p.m. Eastern Standard Time) to discuss its financial results. A live webcast of the event will … Read more

Perimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update

by

Hosting Call on Thursday, May 25th at 5 pm ET TORONTO and DALLAS, May 18, 2023 /PRNewswire/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – announced it will report its first quarter 2023 financial and operating results after the close … Read more

PTC Therapeutics Announces APHENITY Trial Achieved Primary Endpoint with Sepiapterin in PKU Patients

by

– Highly statistically significant and clinically meaningful results – – 63% mean blood Phe reduction in primary analysis population (p<0.0001) – – Conference call and webcast to be held at 8:00 AM EDT – SOUTH PLAINFIELD, N.J., May 17, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the primary endpoint was achieved in … Read more

Invitation to Immunovia’s Q1 presentation

by

LUND, Sweden, May 17, 2023 /PRNewswire/ — Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com Jeff Borcherding, CEO … Read more

Invitation to Immunovia’s Q1 presentation

by

LUND, Sweden, May 17, 2023 /PRNewswire/ — Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com Jeff Borcherding, CEO … Read more